Kansikuva

Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime/colistin versus gentamicin/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm

Abstract Background Carbapenem-resistant Pseudomonas aeruginosa (CRPA) represents an escalating healthcare hazard with high mortality worldwide, especially in presence of biofilm. The current study aimed to evaluate the anti-biofilm potentials of ceftazidime, colistin, gentamicin, and meropenem alon...

Tallennettuna:

Bibliografiset tiedot
Päätekijät:	Mona Shaban E. M. Badawy (Tekijä), Walid F. Elkhatib (Tekijä), Rania I. Shebl (Tekijä)
Aineistotyyppi:	Kirja
Julkaistu:	BMC, 2023-07-01T00:00:00Z.
Aiheet:	article
Linkit:	Connect to this object online.
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia

Novel in vitro pharmacodynamic model simulating ofloxacin pharmacokinetics in the treatment of Pseudomonas aeruginosa biofilm-associated infections
Tekijä: Ayman M. Noreddin, et al.
Julkaistu: (2009)

Modulating the transcriptomic profile of multidrug-resistant Klebsiella pneumoniae biofilm formation by antibiotics in combination with zinc sulfate
Tekijä: Rania I. Shebl, et al.
Julkaistu: (2023)

Colistin-resistant Pseudomonas aeruginosa clinical strains with defective biofilm formation
Tekijä: Azimi, Leila, et al.
Julkaistu: (2019)

Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>
Tekijä: Anthony Sophonsri, et al.
Julkaistu: (2024)

Evaluating of the Effects of Sub-MIC Concentrations of Gentamicin on Biofilm Formation in Clinical Isolates of Pseudomonas aeruginosa
Tekijä: Zahra Yousefpour, et al.
Julkaistu: (2021)

Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant <i>Pseudomonas aeruginosa</i> Biofilm
Tekijä: Cristina El Haj, et al.
Julkaistu: (2024)

Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
Tekijä: Márió Gajdács
Julkaistu: (2020)

Carbapenem Resistance Related with Biofilm Formation and Pilin Genes in Clinical Pseudomonas aeruginosa Isolates
Tekijä: Huda M. Mahmood, et al.
Julkaistu: (2024)

Bloodstream Infections Due to Wild-Type <i>Pseudomonas aeruginosa</i>: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes
Tekijä: Carlo Pallotto, et al.
Julkaistu: (2024)

Unexpected induction of resistant Pseudomonas aeruginosa biofilm to fluoroquinolones by diltiazem: A new perspective of microbiological drug-drug interaction
Tekijä: Walid F. ElKhatib, et al.
Julkaistu: (2008)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
Tekijä: Jae-Min Park, et al.
Julkaistu: (2021)

Challenging T > MIC Using Meropenem vs. Escherichia coli and Pseudomonas aeruginosa
Tekijä: A. Nussbaumer-Pröll, et al.
Julkaistu: (2022)

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>
Tekijä: George L. Daikos, et al.
Julkaistu: (2021)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
Tekijä: Jacinda C. Abdul-Mutakabbir, et al.
Julkaistu: (2021)

Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant <i>Pseudomonas aeruginosa</i> and Minimize Biofilm Formation
Tekijä: Hasini Wickremasinghe, et al.
Julkaistu: (2021)

In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
Tekijä: Rémy A. Bonnin, et al.
Julkaistu: (2023)

Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa
Tekijä: María José Contreras-Gómez, et al.
Julkaistu: (2022)

German Multicenter Study Analyzing Antimicrobial Activity of Ceftazidime-Avibactam of Clinical Meropenem-Resistant <i>Pseudomonas aeruginosa</i> Isolates Using a Commercially Available Broth Microdilution Assay
Tekijä: Jana Manzke, et al.
Julkaistu: (2022)

Effectiveness and Nephrotoxicity of Loading Dose Colistin-Meropenem versus Loading Dose Colistin-Imipenem in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
Tekijä: Wasan Katip, et al.
Julkaistu: (2022)

XDR-<i>Pseudomonas aeruginosa</i> Outside the ICU: Is There Still Place for Colistin?
Tekijä: Paola Del Giacomo, et al.
Julkaistu: (2022)

In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection
Tekijä: Walid Elkhatib, et al.
Julkaistu: (2014)

Conjugation of Gentamicin to Polyamidoamine Dendrimers Improved Anti-bacterial Properties against Pseudomonas aeruginosa
Tekijä: Hamed Sheykhloo, et al.
Julkaistu: (2021)

Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation
Tekijä: Dai Y, et al.
Julkaistu: (2021)

In vitro antibacterial activity of imipenem in combination with colistin against multidrug-resistant Pseudomonas aeruginosa
Tekijä: Sirinat Phanuwong
Julkaistu: (2014)

Genetic Alternatives for Experimental Adaptation to Colistin in Three <i>Pseudomonas aeruginosa</i> Lineages
Tekijä: Igor Chebotar, et al.
Julkaistu: (2024)

Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of <i>Enterobacterales</i> (<i>Enterobacteriaceae</i>) and <i>Pseudomonas aeruginosa</i> to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods
Tekijä: Venere Cortazzo, et al.
Julkaistu: (2022)

The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial
Tekijä: Mahnaz Momenzadeh, et al.
Julkaistu: (2023)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii-calcoaceticus Complex</i>
Tekijä: Rebeca Carvalho Lacerda Garcia, et al.
Julkaistu: (2023)

Inhibition of Pseudomonas aeruginosa PAO1 adhesion to and invasion of A549 lung epithelial cells by natural extracts
Tekijä: Ghada F. Ahmed, et al.
Julkaistu: (2014)

Activity of Temporin A and Short Lipopeptides Combined with Gentamicin against Biofilm Formed by <i>Staphylococcus</i> <i>aureus</i> and <i>Pseudomonas aeruginosa</i>
Tekijä: Malgorzata Anna Paduszynska, et al.
Julkaistu: (2020)

Ceftazidime/Tobramycin Co-Loaded Chitosan-Coated Zein Nanoparticles against Antibiotic-Resistant and Biofilm-Producing <i>Pseudomonas aeruginosa</i> and <i>Klebsiella pneumoniae</i>
Tekijä: Luís André de Almeida Campos, et al.
Julkaistu: (2024)

Survey of VA Laboratory Practices for Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
Tekijä: Aubrey Sawyer, et al.
Julkaistu: (2024)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
Tekijä: Wasan Katip, et al.
Julkaistu: (2020)

Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
Tekijä: Zahra Chegini, et al.
Julkaistu: (2020)

Antimicrobial Contribution of Chitosan Surface-Modified Nanoliposomes Combined with Colistin against Sensitive and Colistin-Resistant Clinical <i>Pseudomonas aeruginosa</i>
Tekijä: Valentina Laverde-Rojas, et al.
Julkaistu: (2020)

Clinical Significance of Carbapenem-Tolerant <i>Pseudomonas aeruginosa</i> Isolated in the Respiratory Tract
Tekijä: Momoyo Azuma, et al.
Julkaistu: (2020)

Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of <i>Pseudomonas aeruginosa</i> Phages
Tekijä: Katarzyna M. Danis-Wlodarczyk, et al.
Julkaistu: (2021)

A patient presenting with cholangitis due to Stenotrophomonas maltophilia and Pseudomonas aeruginosa successfully treated with intrabiliary colistine
Tekijä: Pablo N. Pérez, et al.
Julkaistu: (2014)

Inhibition study of biofilms production of Pseudomonas aeruginosa strains in the presence of propolis
Tekijä: Lorena Abadía-Patiño, et al.
Julkaistu: (2020)

In vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa
Tekijä: Ghorbani, Hossein, et al.
Julkaistu: (2017)